FAMILY MEDICINE SHELF (USPSTF +
BLUEPRINTS + AAFP QUESTIONS) 2026 |
COMPLETE STUDY GUIDE & PRACTICE
QUESTIONS
| GRADED A+ | GUARANTEED SUCCESS
Updated 2026 Questions and Answers
100% Verified Exam Prep and Comprehensive
Rationales Included
,Recommendation for Aspirin Usage Men 45-79 years old (MI protection)
Women 55-79 (Stroke protection)
*Benefit of MI reduction must outweigh the risk of GI hemorrhage
Risk Factors For GI Hemorrhage Men
Other NSAID usage
Hx of GI ulcer
Uncontrolled HTN
Anticoagulation
Screening for Asymptomatic Bacteriuria Women at 12-16 weeks of pregnancy or first prenatal visit if farther along
Screening Test for Asymptomatic Bacteriuria Urine culture
Dipstick and microscopy have poor PPV and NPV
Treatment for Asymptomatic Bacteriuria Nitrofurantoin
Prophylactic Aspirin for the Prevention of Colon Cancer The USPSTF DOES NOT recommend this due to risk of GI hemorrhage
Bacterial Vaginosis Screening in Pregnant Women The USPSTF DOES NOT recommend this due to lack of evidence that it reduces
mortality or morbidity
Amsel Criteria Need 3/4:
1. Fishy odor with addition of KOH
2. Vaginal pH >4.7
3. Clue cells on wet mount
4. Thin, homogenous discharge
Treatment of BV Oral Metronidazole or oral Clindamycin
or
Vaginal Metronidazole or Vaginal Clindamycin creams
Screening for Bladder Cancer The USPSTF DOES NOT recommend this due to lack of accurate screening
methods
Screening for HTN Adults > 18 years
Diagnosis of HTN >140 systolic or >90 diastolic
Must have 2 different BP readings that are elevated over a period of 1-several
weeks
,Categories of BP Normal = <120/<80
PreHTN = 120-129/80-89
Stage 1 HTN = 140-159/90-99
Stage 2 HTN = 160+/100+
Major CV Risk Factors HTN
Obesity
Dyslipidemia
DM
Cigarette smoking
Inactivity
Age >55 (men) or >65 (women
Family History of premature CVD: <55 (men) and <65 (women)
Causes of HTN Sleep Apnea
Drug-induced (diuretics, cyclosporine, glucocorticoids, amiodarone)
Chronic kidney disease
Primary Aldosteronism (Conn's Syndrome)
Cushing's Syndrome
Pheochromocytoma (MEN II and III)
Coarctation of aorta (Turner's)
Thyroid/Parathyroid disease
Goal BPs for Treatment (JNC8) <140/90 for adults <60 years without CKD
<150/90 for adults >60 years without CKD
<140/90 for all ages with DM, but no CKD
<140/90 for all ages with CKD +/- DM
Treatment of HTN for Non-Black without CKD Thiazide Diuretic
ACE-I
ARB
CCB
Treatment of HTN for Black without CKD Thiazide Diuretic
CCB
Treatment of HTN for All Races with CKD +/- DM ACE-I
ARB
BRCA-Related Cancer Screening All women with family members who had breast, ovarian, tubal, and/or peritoneal
cancers
, Medications for Breast Cancer Risk Reduction Offer tamoxifen or raloxifene to women at high risk with low risk for adverse side
effects
Mammography Screening Women 50-74: biennial (every other year)
Women under 50: Take the patient's factors into context and weigh benefits and
risks
Women >75: not recommended to get screening
Breastfeeding recommendations Interventions to educate and encourage women during pregnancy and postnatal
period to breastfeed
Carotid Artery Stenosis Screening USPSTF DOES NOT recommend screening for the general population for
asymptomatic carotid stenosis
Diagnostic Test for Carotid Artery Stenosis Ultrasonography of Carotid Artery with Doppler flow
High Intensity Statin Lowers LDL-C by >/=50%
Atorvostatin 40-80 mg
Rosuvostatin 20-40 mg
Medium Intensity Statin Lowers LDL-C by 30-50%
Atorvostatin 10-20 mg
Rosuvostatin 5-10 mg
Simvastatin 20-40 mg
Provastatin 40-80 mg
Lovastatin 40 mg
Fluvastatin 40 mg BID
Low Intensity Statin Lowers LDL-C by </=30%
Pravastatin 10-20 mg
Lovastatin 20 mg
Cervical Cancer Screening Women 21-65 Pap smear with cytology Q3 years
Women 30-65 Pap smear with HPV testing Q5 years
Cervical Cancer Screening Exemptions Women >65 years with previously normal screenings
Women who had a hysterectomy with removal of the cervix and no history of
precancerous lesion
BLUEPRINTS + AAFP QUESTIONS) 2026 |
COMPLETE STUDY GUIDE & PRACTICE
QUESTIONS
| GRADED A+ | GUARANTEED SUCCESS
Updated 2026 Questions and Answers
100% Verified Exam Prep and Comprehensive
Rationales Included
,Recommendation for Aspirin Usage Men 45-79 years old (MI protection)
Women 55-79 (Stroke protection)
*Benefit of MI reduction must outweigh the risk of GI hemorrhage
Risk Factors For GI Hemorrhage Men
Other NSAID usage
Hx of GI ulcer
Uncontrolled HTN
Anticoagulation
Screening for Asymptomatic Bacteriuria Women at 12-16 weeks of pregnancy or first prenatal visit if farther along
Screening Test for Asymptomatic Bacteriuria Urine culture
Dipstick and microscopy have poor PPV and NPV
Treatment for Asymptomatic Bacteriuria Nitrofurantoin
Prophylactic Aspirin for the Prevention of Colon Cancer The USPSTF DOES NOT recommend this due to risk of GI hemorrhage
Bacterial Vaginosis Screening in Pregnant Women The USPSTF DOES NOT recommend this due to lack of evidence that it reduces
mortality or morbidity
Amsel Criteria Need 3/4:
1. Fishy odor with addition of KOH
2. Vaginal pH >4.7
3. Clue cells on wet mount
4. Thin, homogenous discharge
Treatment of BV Oral Metronidazole or oral Clindamycin
or
Vaginal Metronidazole or Vaginal Clindamycin creams
Screening for Bladder Cancer The USPSTF DOES NOT recommend this due to lack of accurate screening
methods
Screening for HTN Adults > 18 years
Diagnosis of HTN >140 systolic or >90 diastolic
Must have 2 different BP readings that are elevated over a period of 1-several
weeks
,Categories of BP Normal = <120/<80
PreHTN = 120-129/80-89
Stage 1 HTN = 140-159/90-99
Stage 2 HTN = 160+/100+
Major CV Risk Factors HTN
Obesity
Dyslipidemia
DM
Cigarette smoking
Inactivity
Age >55 (men) or >65 (women
Family History of premature CVD: <55 (men) and <65 (women)
Causes of HTN Sleep Apnea
Drug-induced (diuretics, cyclosporine, glucocorticoids, amiodarone)
Chronic kidney disease
Primary Aldosteronism (Conn's Syndrome)
Cushing's Syndrome
Pheochromocytoma (MEN II and III)
Coarctation of aorta (Turner's)
Thyroid/Parathyroid disease
Goal BPs for Treatment (JNC8) <140/90 for adults <60 years without CKD
<150/90 for adults >60 years without CKD
<140/90 for all ages with DM, but no CKD
<140/90 for all ages with CKD +/- DM
Treatment of HTN for Non-Black without CKD Thiazide Diuretic
ACE-I
ARB
CCB
Treatment of HTN for Black without CKD Thiazide Diuretic
CCB
Treatment of HTN for All Races with CKD +/- DM ACE-I
ARB
BRCA-Related Cancer Screening All women with family members who had breast, ovarian, tubal, and/or peritoneal
cancers
, Medications for Breast Cancer Risk Reduction Offer tamoxifen or raloxifene to women at high risk with low risk for adverse side
effects
Mammography Screening Women 50-74: biennial (every other year)
Women under 50: Take the patient's factors into context and weigh benefits and
risks
Women >75: not recommended to get screening
Breastfeeding recommendations Interventions to educate and encourage women during pregnancy and postnatal
period to breastfeed
Carotid Artery Stenosis Screening USPSTF DOES NOT recommend screening for the general population for
asymptomatic carotid stenosis
Diagnostic Test for Carotid Artery Stenosis Ultrasonography of Carotid Artery with Doppler flow
High Intensity Statin Lowers LDL-C by >/=50%
Atorvostatin 40-80 mg
Rosuvostatin 20-40 mg
Medium Intensity Statin Lowers LDL-C by 30-50%
Atorvostatin 10-20 mg
Rosuvostatin 5-10 mg
Simvastatin 20-40 mg
Provastatin 40-80 mg
Lovastatin 40 mg
Fluvastatin 40 mg BID
Low Intensity Statin Lowers LDL-C by </=30%
Pravastatin 10-20 mg
Lovastatin 20 mg
Cervical Cancer Screening Women 21-65 Pap smear with cytology Q3 years
Women 30-65 Pap smear with HPV testing Q5 years
Cervical Cancer Screening Exemptions Women >65 years with previously normal screenings
Women who had a hysterectomy with removal of the cervix and no history of
precancerous lesion
